WASHINGTON -- While the Biotechnology Summit held here onMonday failed to establish a national agenda for the industry, anumber of good ideas surfaced nonetheless.

-- Herbert Pardes, dean of the College of Physicians andSurgeons at Columbia University, said the public needed tounderstand the role of the countryUs 140 academic healthcenters, which not only educate doctors and provide half of allcare that goes to the needy, but are where most of the newgenetic discoveries have taken place.

"The value of the research is so that people can live as manyyears as possible free of symptoms and pain," said Pardes,quoting former Aging Institute Director Robert Butler.

-- Terry Lierman, president of public relations firm CapitolAssociates, recommended supporting the Harkin-Hatfield trustfund. This legislation could provide $5 billion a year to theNational Institutes of Health -- half again as much as theagency already spends -- by placing a tiny tax on each medicalvisit.

-- The Biotechnology Industry Organization (BIO) stressed thevalue of education, noting that in a nationwide college contest,students will compete for college scholarship money by writingessays on what biotechnology will mean in the 21st century.BIO also conducts outreach to patient groups. RBut IUmcompeting with a cacophony of 200-300 other voices that wantto be heard on health-care reform alone," said BIO PresidentCarl Feldbaum. -- David C. Holzman

(c) 1997 American Health Consultants. All rights reserved.